(NASDAQ: XRAY) Dentsply Sirona's forecast annual revenue growth rate of -0.3% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.93%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.87%.
Dentsply Sirona's revenue in 2024 is $3,900,000,000.On average, 8 Wall Street analysts forecast XRAY's revenue for 2024 to be $756,839,091,811, with the lowest XRAY revenue forecast at $754,304,851,098, and the highest XRAY revenue forecast at $759,159,048,149. On average, 9 Wall Street analysts forecast XRAY's revenue for 2025 to be $750,295,864,771, with the lowest XRAY revenue forecast at $734,669,405,371, and the highest XRAY revenue forecast at $787,167,089,280.
In 2026, XRAY is forecast to generate $773,012,791,361 in revenue, with the lowest revenue forecast at $748,285,805,779 and the highest revenue forecast at $810,424,298,736.